A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects

NCT02285465 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study terminated due to sponsor decision

Conditions

Healthy Volunteers
Pharmacokinetics of ASP3700

Interventions

DRUG: ASP3700
DRUG: Placebo

Sponsor

Astellas Pharma Europe B.V.